• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    4.19 Down 0.01(0.24%) May 22, 4:00PM EDT
    |After Hours : 4.18 Down 0.01 (0.24%) May 22, 5:49PM EDT
    Add to Portfolio
    Prev Close:4.20
    Open:4.18
    Bid:N/A
    Ask:4.65 x 200
    1y Target Est:7.08
    Beta:-4.69
    Earnings Date:Jul 30 - Aug 3 (Est.)
    Day's Range:4.14 - 4.26
    52wk Range:3.26 - 6.59
    Volume:1,629,906
    Avg Vol (3m):3,907,950
    Market Cap:1.01B
    P/E (ttm):N/A
    EPS (ttm):-0.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARNADown 0.24%1.01B
    GSKDown 0.66%109.30B
    OREXUp 0.20%619.88M
    RHHBYDown 0.94%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):27.43
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.52
    Quarterly EPS Est (Jun-15) :-0.14
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.40

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback